Biogen's selling, general and administrative costs 2016-2023
This statistic shows Biogen's selling, general and administrative (SG&A) costs from 2014 to 2023, in million U.S. dollars. SG&A costs stood at 2.55 billion U.S. dollars in 2023. Biogen Inc. is a Massachusetts-based biotech company, specialized in drugs for neurological disorders, autoimmune disorders and cancer.